Mustafa Ozer/AFP/Getty Images
To the list of hundreds of schools, hospitals, and community health centers that have received limited allocations of the H1N1 swine flu vaccine, you can now add some of New York's largest employers. In the past week or so 13 companies, including Citigroup (C) and Goldman Sachs (GS), have begun receiving small quantities of the vaccine, according to city health authorities.
Citigroup has been supplied with 1,200 units and Goldman with 200, says Jessica Scaperotti, press secretary for the Department of Health & Mental Hygiene. The agency has so far approved orders by 29 employers—including 16 that have yet to receive any vaccine—after they were cleared by the U.S. Centers for Disease Control & Prevention (CDC). Big employers that have received or are scheduled to receive vaccine so far include Time Warner (TWX), JPMorgan Chase (JPM), Memorial Sloan-Kettering, New York Presbyterian Healthcare System, and New York University.
Health-care workers at those employers are bound by the CDC to distribute the vaccine only to populations deemed to be at high risk of developing serious complications from swine flu: pregnant women, children and young people aged 6 months to 24 years, people who live with or provide care for infants under 6 months (who cannot be vaccinated), people aged 24 to 64 with medical conditions that put them at higher risk for flu-related complications, and health-care workers and emergency medical personnel. A spokeswoman for Goldman, who asked not to be named, said the company had just received the vaccine and did not yet have information as to how it would be distributed, saying that Goldman will supply vaccine only to those who qualify as high-risk, per the CDC requirements. Citigroup had not responded with a comment as of the evening of Nov. 2.
According to the city, Goldman has requested 5,300 doses. Only the company's two Manhattan locations are eligible to receive the vaccine because Goldman's other regional offices lack on-site health units, the spokesperson said. So far, only the 85 Broad St. location has received vaccine. The spokeswoman said the company knows of no employee who has fallen ill with swine flu, "but obviously you have to be prepared."
Like many large employers, Goldman Sachs has been preparing to deal with swine flu for months. "In addition to the internal planning effort, we have been actively engaged with key firms in our supply chain, industry peers, regulators and exchanges, and local health authorities to ensure mutual support and coordination of efforts," the company said in a public statement on May 6.
"It's not that they received it over someone else, it's that they placed an order…This is not out of the ordinary," says Scaperotti of the city's health office. "A lot of businesses hold vaccination programs for their employees. These locations are important vehicles for vaccinating people."
New York has a comprehensive vaccination program for schoolchildren, Scaperotti says. It is currently vaccinating pupils in elementary schools and will begin weekend vaccination clinics for middle- and high school kids next weekend. Any New Yorkers who do not have primary-care physicians can go to the city's vaccine locator Web site to find vaccination sites in their communities.
Responsibility for developing individual vaccination plans normally falls to the states, which place all swine flu vaccine orders for registered health-care providers with the CDC. But New York's five boroughs fall under the jurisdiction of the city's Health & Mental Hygiene Dept. McKesson (MCK), a San Francisco-based health-care services and IT company, distributes all vaccination doses and the ancillary medical supplies that health providers need to administer them.
Track and share business topics across the Web.